Agin-Liebes G
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
ArticlePsilocybin
Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD.
ArticlePsilocybin
Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD.
PreprintPsilocybin
Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD
PreprintPsilocybin
Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial
ArticlePsilocybin
Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.
ArticlePsilocybin
Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.
PreprintPsilocybin
Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion
PreprintPsilocybin
Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder
ArticleMDMA
Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder.
ArticlePsilocybin
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
ArticlePsilocybin
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.
ArticlePsilocybin
Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.
ArticlePsilocybin
Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
ArticlePsilocybin
The need for establishing best practices and gold standards in psychedelic medicine.
ArticlePsilocybin
Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.
ArticleAyahuasca
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca.
ArticlePsilocybin
Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.
ArticleMescaline
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.
ArticlePsilocybin
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.
ArticlePsilocybin